Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
type 1 diabetes
5
×
biotech
clinical trials
indiana blog main
life sciences
national blog main
new york blog main
boston blog main
boston top stories
diabetes
eli lilly
fda
indiana top stories
new york top stories
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
amgen
beta bionics
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
deals
detroit blog main
detroit top stories
investing
medical device
medicare
national
national top stories
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
startups
texas blog main
texas top stories
venture capital
What
diabetes
patients
type
bio
drug
eli
key
roundup
advantages
appetite
approval
bar
beta
bid
bionics
black
blood
boehringer
bread
brings
butter
buyout
cancer
cash
catch
catching
closed
developing
device
diamond’s
driven
drugs
earlier
early
expand
expect
fallen
fda
gamble
giant
Language
unset
Current search:
" type 1 diabetes "
×
@xconomy.com
10 months ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
1 year ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@engadget.com
1 year ago
AI could be the key to catching Type 1 diabetes much earlier
@xconomy.com
2 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
2 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests